Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 10 (RPL17P10)

Target: RPL17P10
Molecular classification: Other

Overview

Ribosomal protein L17 pseudogene 10 is one of multiple processed pseudogenes derived from the ribosomal protein L17 gene (RPL17), which encodes a component of the 60S ribosomal subunit involved in cellular protein biosynthesis. Pseudogenes like RPL17P10 do not produce functional protein products and are considered genomic relics rather than functional receptors or targets; therefore, they are not considered therapeutic targets and have no known direct biological function, disease role, or relevance to drug targeting.

Other names: RPL17_2_309

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 10 (RPL17P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 10 (RPL17P10).

Explore the full profile